[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:
10.1177/1060028018797110[2] N A SHARIF J M Y S X Xu. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.[J]. Journal of Ocular Pharmacology and Therapeutics, 1996, 12 4: 401-407. DOI:
10.1089/jop.1996.12.401[3] A. BABA. Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties[J]. Cellular Physiology and Biochemistry, 2016, 38 1: 15-27. DOI:
10.1159/000438605[4] Y NISHIKAWA. Acrylamide derivatives as antiallergic agents. III. Synthesis and structure-activity relationships of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]- and N-[4-(4-diphenylmethylene-1-piperidyl)butyl]-3-heteroarylacry lamides.[J]. Chemical & pharmaceutical bulletin, 1989, 37 3: 684-687. DOI:
10.1248/cpb.37.684[5] NAOKI MIYAGAWA. Two pharmacological phases in antigen-induced immediate airway response in rats.[J]. Biological & pharmaceutical bulletin, 2008, 31 12: 2260-2264. DOI:
10.1248/bpb.31.2260
